Effect of recombinant human keratinocyte growth factor (rHuKGF) on the immunopathogenesis of intestinal graft-vs.-host disease induced without a preconditioning regimen

Journal of Clinical Immunology

Volumn 24, Issue 2, 2004, Pages 197-211

  Ellison, Cynthia A ^a,b   Natuik, Shannon A ^a   Fischer, Jacqie M M ^a   McIntosh, Alan R ^a   Scully, Sheila A ^c   Bow, Eric J ^a,b   Danilenko, Dimitry M ^c   Hayglass, Kent T ^a   Gartner, John G ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CancerCare Manitoba ^*  (Canada)

^c AMGEN INC   (United States)

Author keywords

Cytokines; Graft vs. host; Intestinal GVHD; Keratinocyte growth factor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; RECOMBINANT KERATINOCYTE GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTOXEMIA; FEMALE; GRAFT VERSUS HOST REACTION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE EPITHELIUM CELL; INTESTINE TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; APOPTOSIS; CELL TRANSPLANTATION; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; GRAFT VS HOST DISEASE; HUMANS; INTESTINES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; NITRIC OXIDE; RECOMBINANT PROTEINS; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTE SUBSETS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1842503194     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOCI.0000019785.35850.a5     Document Type: Article

References (43)

1. Martin PJ, Hansen JA, Buckner CD, Sanders JE, Deeg HJ, Stewart P, Appelbaum FR, Clift R, Fefer A, Witherspoon RP, et al.: Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66:664-672, 1985
2. Papa G, Arcese W, Mauro FR, Bianchi A, Alimena G, De Felice L, Isacchi G, Pasqualetti D, Malagnino F, Purpura M, et al.: Standard conditioning regimen and T-depleted donor bone marrow for transplantation in chronic myeloid leukemia. Leuk Res 10:1469-1475. 1986
3. Rus V, Syctic A, Nguyen P, Gause WC, Via CS: Kinetics of Th1 and Th2 cytokine production during the early course of acule and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells. J Immunol 155:2396-2406, 1995
4. Ghayur T, Seemayer TA, Kongshavn PA, Gartner JG, Lapp WS: Graft-versus-host reactions in the beige mouse. An investigation of the role of host and donor natural killer cells in the pathogenesis of graft-versus-host disease. Transplantation 44:261-267, 1987
5. MacDonald GC, Gartner JG: Prevention of acute lethal graft-versus-host disease in F1 hybrid mice by pretreatment of the graft with anti-NK-1.1 and complement. Transplantation 54:147-151, 1992
6. Ellison CA, HayGlass KT, Fischer JM, Rector ES, MacDonald GC, Gartner JG: Depletion of natural killer cells from the graft reduces interferon-gamma levels and lipopolysaccharide-induced tumor necrosis factor-alpha release in F1 hybrid mice with acute graft-versus-host disease. Transplantation 66:284-295, 1998.
7. Woodruff JM, Eltringham JR, Casey HW: Early secondary disease in the Rhesus monkey. I. A comparative histopathologic study. Lab Invest 20:499-511, 1969
8. Nestel FP, Price KS, Seemayer TA, Lapp WS: Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med 175:405-413, 1992
9. Stuber E, Buschenfeld A, von Freier A, Arendt T, Folsch UR: Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor alpha and not by the FasL-Fas interaction: Effect of penloxifylline on the development of mucosal atrophy. Gut 45:229-235, 1999
10. Garside P, Hutton AK, Severn A, Liew FY, Mowat AM: Nitric oxide mediates intestinal pathology in graft-vs.-host disease. Eur J Immunol 22:2141-2145, 1992
11. Min D, Taylor PA, Panoskaltsis-Mortari A, Chung B, Danilenko DM, Farrell C, Lacey DL, Blazar BR, Weinberg KI: Protection from thymic epithelial cell injury by keratinocyte growth factor: A new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 99:4592-4600, 2002
12. Panoskaltsis-Mortari A, Lacey DL, Vallera DA, Blazar BR: Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice. Blood 92:3960-3967, 1998
13. Panoskaltsis-Mortari A, Taylor PA, Rubin JS, Uren A, Welniak LA. Murphy WJ, Farrell CL, Lacey DL, Blazar BR: Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury. Blood 96:4350-4356, 2000
14. Rossi S, Blazar BR, Farrell CL, Danilenko DM, Lacey DL, Weinberg KI, Krenger W, Hollander GA: Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood 100:682-691, 2002
15. Krijanovski OI, Hill GR, Cooke KR, Teshima T, Crawford JM, Brinson YS, Ferrara JL: Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease. Blood 94:825-331, 1999
16. Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA: Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245:752-755, 1989
17. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA: Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 86:802-806, 1989
18. Boismenu R, Havran WL: Modulation of epithelial cell growth by intraepithelial gamma delta T cells. Science 266:1253-1255, 1994
19. Yi ES, Shabaik AS, Lacey DL, et al.: Keratinocyte growth factor causes proliferation of urothelium in vivo. J Urol 154:1566-1570, 1995
20. Staiano-Coico L, Krueger JG, Rubin JS, D'Limi S, Vallat VP, Valentino L, Fahey T, 3rd, Hawes A, Kingston G, Madden MR. et al.: Human keratinocyte growth factor effects in a porcine model of epidermal wound healing. J Exp Med 178:865-878, 1993
21. Bottaro DP, Rubin JS, Ron D, Finch PW, Florio C, Aaronson SA: Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. J Biol Chem 265:12767-12770, 1990
22. Housley RM, Morris CF, Boyle W, Ring B, Biltz R, Tarpley JE, Aukerman SL, Devine PL, Whitehead RH, Pierce GF: Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 94:1764-1777, 1994
23. Pierce GF, Yanagihara D, Klopchin K, Danilenko DM, Hsu E, Kenney WC, Morris CF: Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor. J Exp Med 179:831-840, 1994
24. Panos RJ, Rubin JS, Csaky KG, Aaronson SA, Mason RJ: Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. J Clin Invest 92:969-977, 1993
25. Ulich TR, Yi ES, Cardiff R, Yin S, Bikhazi N, Biltz R, Morris CF, Pierce GF: Keratinocyte growth factor is a growth factor for mammary epithelium in vivo. The mammary epithelium of lactating rats is resistant to the proliferative action of keratinocyte growth factor. Am J Pathol 144:862-568, 1994
26. Parrott JA, Kim G, Mosher R, Skinner MK: Expression and aclion of keratinocyte growth factor (KGF) in normal ovarian surface epithelium and ovarian cancer. Mol Cell Endocrinol 167:77-87, 2000
27. Yi ES, Williams ST, Lee H, Malicki DM, Chin EM, Yin S, Tarpley J, Ulich TR: Keratinocyte growth factor ameliorates radiation-and bleomycin-induced lung injury and mortality. Am J Pathol 149:1963-1970, 1996
28. Ulich TR, Whitcomb L, Tang W, O'Conner Tressel P, Tarpley J, Yi ES, Lacey D: Keratinocyte growth factor ameliorates cyclophosphamide-induced ulcerative hemorrhagic cystitis. Cancer Res 57:472-475, 1997
29. Farrell CL, Bready JV, Rex KL, Chen JN, DiPalma CR, Whitcomb KL, Yin S, Hill DC, Wiemann B, Staraes CO, Havill AM, Lu ZN, Aukerman SL, Pierce GF, Thomason A, Rotten CS, Ulich TR, Lacey DL: Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 58:933-939, 1998
30. Frank S, Munz B, Werner S: The human homologue of a bovine non-selenium glutathione peroxidase is a novel keratinocyte growth factor-regulated gene. Oncogene 14:915-921, 1997
31. Takeoka M, Ward WF, Pollack H, Kamp DW, Panos RJ: KGF facilitates repair of radiation-induced DNA damage in alveolar epithelial cells. Am J Physiol 272:L1174-1180, 1997
32. Gartner JG, Merry AC, Smith CI: An analysis of pulmonary natural killer cell activity in F1-hybrid mice with acute graft-versus-host reactions. Transplantation 46:879-886, 1988
33. Ellison CA, Fischer JM, HayGlass KT, Gartner JG: Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors. J Immunol 161:631-640, 1998
34. Yang X, Gieni RS, Mosmann TR, HayGlass KT: Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. J Exp Med 178:349-353, 1993
35. Ellison CA, Natuik SA, McIntosh AR, Scully SA, Danilenko DM, Gartner JG: The role of interferon-gamma, nitric oxide and lipopolysaccharide in intestinal graft-versus-host disease developing in F1-hybrid mice. Immunology 109:440-449, 2003
36. Kubrina LN, Caldwell WS, Mordvintcev PI, Malenkova IV, Vanin AF: EPR evidence for nitric oxide production from guanidino nitrogens of L-arginine in animal tissues in vivo. Biochim Biophys Acta 1099:233-237, 1992
37. Komarov AM, Lai CS: Detection of nitric oxide production in mice by spin-trapping electron paramagnetic resonance spectroscopy. Biochim Biophys Acta 1272:29-36, 1995
38. Privat C, Lantoine F, Bedioui F, Millanvoye van Brussel E, Devynck J, Devynck MA: Nitric oxide production by endothelial cells; Comparison of three methods of quantification. Life Sci 61:1193-1202, 1997
39. Wang HH, McIntosh AR, Hasinoff BB, Rector ES, Ahmed N, Nance DM, Orr FW: B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: A natural hepatic defense against metastasis. Cancer Res 60:5862-5869, 2000
40. Ellison CA, Amadeo RJ, Gartner JG: GVHD-associated enteropathy and endotoxemia in F1-hybrid recipients of NK1.1-depleted grafts. Scand J Immunol 54:375-382, 2001
41. Price KS, Nestel FP, Lapp WS: Progressive accumulation of bacterial lipopolysaccharide in vivo during murine acute graft-versus-host disease. Scand J Immunol 45:294-300, 1997
42. Poltorak A, He X, Smimova I, Liu MY, Van Huffet C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282:2085-2088, 1998
43. Qureshi ST, Lariviere L, Leveque G, Clermont S. Moore KJ, Gros P, Malo D: Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189:615-625, 1999